Healthpeak (DOC) CEO buys 2,930 shares at $17.06 – Form 4 Insight
Healthpeak Properties (DOC) – Form 4 insider activity On 07/31/2025, President & CEO Scott M. Brinker made an open-market purchase (Code “P”) of 2,930 shares of common stock at $17.06 each.
Rhea-AI Filing Summary
Healthpeak Properties (DOC) – Form 4 insider activity
On 07/31/2025, President & CEO Scott M. Brinker made an open-market purchase (Code “P”) of 2,930 shares of common stock at $17.06 each. Following the trade, his direct ownership rose to 210,416 shares; no indirect or derivative holdings were reported.
The filing involves only one transaction, no 10b5-1 plan disclosure and no amendments. While insider buying can signal management’s confidence, the dollar value (≈$50k) and <≈0.04 % of the ≈539 m shares outstanding render the move modestly incremental.
Positive
- CEO participated in open-market purchase, typically interpreted as confidence in future prospects.
Negative
- The transaction size is immaterial relative to both the executive’s existing holdings and the company’s share count, limiting its signaling power.
Insights
TL;DR: Minor CEO buy; positive sentiment but immaterial to valuation.
The purchase marginally lifts Brinker's stake by ~1.4 % (2,930 ÷ 207,486 prior shares) and costs roughly $50k. Such open-market buys usually lean positive, signalling that the CEO deems the stock undervalued around $17. However, relative to Healthpeak’s $9 bn+ market cap, the trade carries negligible financial impact and is unlikely to move the stock. No options or derivative adjustments were disclosed, so dilution risk is unchanged. Overall, sentiment uptick, fundamental effect minimal.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 2,930 | $17.06 | $50K |
FAQ
What is Brinker's total direct ownership after the purchase?
Was the insider action a purchase or sale?
Did the Form 4 include any derivative security transactions?
On what date did the insider transaction occur?
AI-generated analysis. How Rhea-AI works. Not financial advice.